Business Wire

Quanergy Achieves IATF 16949 Automotive Production Certification

Del

Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, today announced that the production line for its solid state LiDAR sensors has achieved IATF 16949 certification.

The International Automotive Task Force (IATF) 16949 is a certification that denotes requirements for a quality management system for organizations within the automotive industry. To qualify and meet certification requirements, Quanergy’s solid state LiDAR production line underwent a thorough quantitative assessment, which consists of 113 tasks within 5 stages that are based on stringent automotive requirements and data obtained through Statistical Process Control (SPC) and Measurement System Analysis (MSA).

The qualification criteria to meet this certification requirement are critical steps towards Quanergy’s goal to bring automotive-grade solid state LiDAR sensors to market. Automotive-grade LiDAR sensors are built using rigorous production processes, which must pass tests that significantly reduce the failure rate of the sensors. While the certification process takes 24 months on average, as a result of Quanergy’s automated facilities, the company was able to gain qualification of this certification in 18 months.

“This latest certification of our production line is a monumental milestone for Quanergy and for the entire LiDAR community,” said Dr. Louay Eldada, CEO of Quanergy. “As automotive and technology companies converge towards a driverless future, the ability to produce automotive-grade solid state LiDAR sensors will be vital. As a result of our team’s hard work and commitment to achieving this certification, Quanergy is leading the way towards this reality.”

Quanergy’s vice president of quality and reliability, Bruce Shibuya, led Quanergy’s various departments and teams to meet this quality standard and achieve qualification of the IATF 16949 certification. Using advanced product quality planning (APQP), Shibuya coordinated internal teams across engineering, production, manufacturing and quality to run reliability tests on all components and completed assemblies as well as qualify the products to meet a strict set of requirements (e.g., thermal cycling, mechanical shock, electrical stress). An industry veteran, Shibuya has established high standards for product quality and reliability as the head of quality departments at companies including Toyota/Lexus, Hyundai/Kia, Nvidia and Jabil.

“IATF 16949 certification opens many doors for Quanergy, which is why our team poured so much effort into earning this distinction,” said Bruce Shibuya, Vice President of Quality and Reliability at Quanergy. “Going through this extremely rigorous process validated our understanding that Quanergy’s products are superior in terms of quality and reliability in all business segments that we are engaged in.”

This qualification of the certification follows the announcement earlier this month that Quanergy obtained another critical quality certification, ISO 9001:2015. As a result of these certifications, Quanergy will now begin mass production of its S3 solid state sensor on its newly certified line.

About Quanergy Systems, Inc.

Quanergy Systems was founded in 2012 and builds on decades of experience of its team in the areas of optics, photonics, optoelectronics, robotics, artificial intelligence, machine learning and controls. Headquartered in Sunnyvale, California, in the heart of Silicon Valley, Quanergy offers the world’s leading LiDAR sensors and software for the capture and processing of 3D spatial data, and object detection, tracking and classification. Its sensing systems improve safety, efficiency and costs in sectors ranging from transportation and security to industrial automation and 3D terrestrial and aerial mapping. In transportation, the data is utilized in real time to greatly improve the accuracy and reliability of on-board driver safety systems and enhance them with perception, scenario analysis, and decision making capability for cost-effective and robust advanced driver assistance systems (ADAS) and autonomous vehicle (AV) solutions. Quanergy’s LiDAR leads in all key commercialization areas – price, performance, reliability, size, weight, power efficiency. For more information, visit www.quanergy.com.

Contact information

Quanergy Systems, Inc.
Ann Gargiulo, +1-408-245-9500
Sr. Director, Marketing Communications
media@quanergy.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha